Objectives-To determine whether HLA-DP genes are involved in determining susceptibility to systemic lupus erythematosus (SLE). Methods-HLA-DPA1 and DPB1 genes were amplified by PCR of DNA samples from a panel of patients with SLE and normal controls. Amplified DNA was blotted on to nylon filters and probed with sequence-specific oligonucleotide (SSO) probes. Results-No DPAl or DPB1 allele was significantly associated with SLE, or with any immunological or clinical subset of SLE. Evidence was found for only limited linkage disequilibrium between HLA-DP and HLA-DQ/DR variants, and none between HLA-DP and the TAP2 gene. Conclusions-These data indicate that HLA-DP genes do not contribute towards determining susceptibility to SLE. (Ann Rheum Dis 1994; 53: 188-190) Systemic lupus erythematosus (SLE) is a clinically heterogeneous connective tissue disorder characterised by immunological abnormalities including autoantibodies to double-stranded (ds) and single-stranded (ss) DNA and to various extractable nuclear antigens, such as Ro, La and U1-RNP. The role of these autoantibodies in the aetiopathogenesis of SLE is poorly understood.
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There is a genetic predisposition to the disease demonstrated by a concordance of approximately 24% in monozygotic twins' compared with only 3%/o in dizygotic twins.2 Part of this genetic predisposition is accounted for by genes within the MHC. There are welldocumented associations of the class II antigens HLA-DR3,3 DR24 and the class III phenotype C4A*QO5 6 with SLE.
Recent studies have found HLA-DQ genes to be more strongly associated with SLE than HLA-DR in certain populations,7 8 suggesting that the main MHC susceptibility gene(s) for SLE may lie more centromeric than previously thought. We have shown that the TAP2 transporter gene, which lies centromeric to HLA-DQ but telomeric to HLA-DP, is not involved in SLE predisposition.9 The limited linkage disequilibrium between TAP2 and DQ/ DR suggests that any disease susceptibility gene centromeric to TAP2 is likely to constitute an independent risk factor for SLE.
Several studies have examined whether HLA-DP genes are involved in determining susceptibility to SLE. Some have found no DP association with SLE,3 1°while others report DP associations either independent of " or secondary to 12 the DR associations. The role of HLA-DP in SLE therefore remains controversial.
We have examined the frequencies of HLA-DPA1 and HLA-DPB1 alleles in UK white patients with SLE to determine whether genes within the DP region are implicated in predisposition to SLE. We have also examined whether linkage disequilibrium exists between HLA-DP and other class II genes in this group of patients.
Materials and methods

SLE AND CONTROL POPULATIONS
White patients with SLE from north west England who fulfilled the ARA revised criteria for SLE'3 were used in this study. Patients were consecutive hospital attenders. Demographic, clinical and immunological details were recorded on a standard proforma. The median age of onset of SLE was 31 years, with a range of 10-78 years. The female:male ratio of the patient group was 9:1. The control samples used in the study consisted of local healthy volunteers.
DNA EXTRACTION
Genomic DNA was extracted from peripheral blood leucocytes as described previously. '4 DPA AND DPB TYPING A standard PCR sequence specific oligonucleotide (SSO) typing procedure was followed. [1] [2] [3] [4] [5] ,ug genomic DNA was amplified with DPA or DPB specific primers. Amplified PCR product (10 [LI) was blotted on to positively charged nylon membrane (Boehringer Mannheim) using a vacuum dot blotter. Membranes were probed with DPB or DPA specific oligonucleotide probes from the British Society for Histocompatibility and Immunogenetics class II oligotyping kit. DPB1 oligonucleotide probes were labelled with digoxi-HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus Linkage disequilibrium analysis in patients with SLE found HLA-DPA1*02 to be associated with DPB1*0101 (A = 0 059) and negatively associated with DPB 1*0401 (A = -0 09 1). Linkage disequilibrium between HLA-DP and HLA-DQ/DR was limited. HLA-DPB 1 *0101 was associated with DQA*0501 (A = 0 052) and DR5 (A = 0.029). HIA-DPB1*0201 was found to be in linkage disequilibrium with DQB*0603 (A = 0 036) and DR13 (A = 0 032). HIA-DPB1*0401 was negatively associated with DR3 (/A = -0 11). HLA-DPB 1*0402 was associated with DQA*0102 (A=0 027) and DQB*0604 (A = 0 026). No HIA-DP alleles were found to be in linkage disequilibrium with any TAP2 allele in our patient population with SLE.
Discussion
In this study we have sought to determine whether genes in the HLA-DP region contribute to SLE susceptibility. No DPA1 or DPB1 allele was found to be associated with SLE. These results agree with the findings of other recent studies. 3 10 We have also found no evidence for any DP allele being associated with immunological or clinical subsets of SLE. HLA-DPB 1*0401 has been reported as being associated with the presence of antibodies to Ul-RNP'5 in connective tissue disease patients, independent of the DR4 association with this subgroup. HLA-DPB1*0301 and DPB1*1401 have increased in SLE, primarily in patients possessing anti-Sm/RNP and anticardiolipin antibodies." We have been unable to confirm these associations in the present study and HLA-DPB1*0301 was found to be nonsignificantly decreased in our patient population with SLE. The failure to observe any DP associations with subgroups of SLE may, however, be due to the relatively small sizes of these groups in this study.
One recent study has reported a significant association of DPB1 *0101 with SLE in a white population.'2 This association was found to be due to linkage disequilibrium of DPB 1*0101 with the HLA-B8 DR3 haplotype. We have also found this allele to be more frequent in our patient population, albeit non-significantly. Linkage disequilibrium analysis shows DPB1*0101 to be associated with DPA1*02, DR5, DR3 (non-significantly) and DQA*0501 (data not shown). These findings are particularly interesting since DQA*0501 is found on both DR3 and DR5 bearing haplotypes and is the allele most strongly associated with SLE in our previous study.8 Such linkage disequilibrium would explain the increased frequencies of DPA1*02 and DPB1*0101 in the anti-La antibody-positive subgroup of SLE, with these increases being secondary to the increased DQA*0501 frequency in this subgroup.8 The limited associations detected between DP and DQ/DR explain why some associations of DP genes with disease are found to be independent of other class II associations while others are not.
Hence the H[A-DQ and DR associations with SLE we have previously reported do not reflect a stronger association with HLA-DP genes, and linkage disequilibrium between DP and DQ/DR is limited. This study provides no evidence that HLA-DP genes play a role in determining susceptibility to SLE.
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